101 related articles for article (PubMed ID: 3873951)
1. [In vitro synthesis of interleukin 2 (IL-2) by T lymphocytes extracted from a lymphoepithelial thymoma. Purification and biochemical characterization].
Ponzoni M; Fenice M; Montaldo P; Tonini GP; Cornaglia-Ferraris P
Boll Ist Sieroter Milan; 1985; 64(1):12-24. PubMed ID: 3873951
[TBL] [Abstract][Full Text] [Related]
2. T cells from lymphoepithelial thymoma produce a biochemical variant of IL-2.
Cornaglia-Ferraris P; Ponzoni M
Lymphokine Res; 1985; 4(3):251-63. PubMed ID: 3875768
[TBL] [Abstract][Full Text] [Related]
3. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and biologic characterization of lymphocyte regulatory molecules. VIII. Purification of interleukin 2 from a human T cell leukemia.
Frank MB; Watson J; Mochizuki D; Gillis S
J Immunol; 1981 Dec; 127(6):2361-5. PubMed ID: 6975318
[TBL] [Abstract][Full Text] [Related]
5. Biological and biochemical characterization of bovine interleukin 2. Studies with cloned bovine T cells.
Brown WC; Grab DJ
J Immunol; 1985 Nov; 135(5):3184-90. PubMed ID: 3930599
[TBL] [Abstract][Full Text] [Related]
6. Thymoma production of T cell growth factor (Interleukin 2).
Farrar JJ; Fuller-Farrar J; Simon PL; Hilfiker ML; Stadler BM; Farrar WL
J Immunol; 1980 Dec; 125(6):2555-8. PubMed ID: 6968789
[TBL] [Abstract][Full Text] [Related]
7. Dissociation in the production of B cell-stimulating factors (BCGF and BCDF) and interleukin 2 by T cells from a common variable immunodeficient patient.
Saiki O; Shimizu M; Saeki Y; Kishimoto S; Kishimoto T
J Immunol; 1984 Oct; 133(4):1920-4. PubMed ID: 6088629
[TBL] [Abstract][Full Text] [Related]
8. Concanavalin A-induced human lymphocyte mitogenic factor: activity distinct from interleukin 1 and 2.
Duncan MR; George FW; Hadden JW
J Immunol; 1982 Jul; 129(1):56-62. PubMed ID: 6806367
[TBL] [Abstract][Full Text] [Related]
9. T-lymphocyte progenitors in man: biochemical characterization of a colony promoting activity (CPA) active on immature precursors.
Triebel F; Gluckman JC; Debre P; Charron DJ
Immunology; 1984 Dec; 53(4):651-7. PubMed ID: 6334017
[TBL] [Abstract][Full Text] [Related]
10. Biochemical characterization of lymphocyte regulatory molecules. II. Purification of a class of rat and human lymphokines.
Gillis S; Smith KA; Watson J
J Immunol; 1980 Apr; 124(4):1954-62. PubMed ID: 6444967
[TBL] [Abstract][Full Text] [Related]
11. Constitutive production by the WEHI-3 cell line of B cell growth and differentiation factor that co-purifies with interleukin 1.
Booth RJ; Prestidge RL; Watson JD
J Immunol; 1983 Sep; 131(3):1289-93. PubMed ID: 6604093
[TBL] [Abstract][Full Text] [Related]
12. Biochemical and biologic characterization of lymphocyte regulatory molecules. IV. Purification of Interleukin 2 from a murine T cell lymphoma.
Mochizuki D; Watson J; Gillis S
J Immunol; 1980 Dec; 125(6):2579-83. PubMed ID: 7000903
[TBL] [Abstract][Full Text] [Related]
13. Biochemical and biologic characterization of lymphocyte regulatory molecules. III. The isolation and phenotypic characterization of Interleukin-2 producing T cell lymphomas.
Gillis S; Scheid M; Watson J
J Immunol; 1980 Dec; 125(6):2570-8. PubMed ID: 6968790
[TBL] [Abstract][Full Text] [Related]
14. [Effects of TCGF (T-cell growth factor) on experimental malignant glioma-specific killer T-cell].
Yamasaki T; Yamashita J; Handa H; Namba Y; Hanaoka M
No Shinkei Geka; 1984 Feb; 12(2):141-50. PubMed ID: 6609319
[TBL] [Abstract][Full Text] [Related]
15. Partial purification and biochemical characterization of a T cell suppressor factor produced by human glioblastoma cells.
Schwyzer M; Fontana A
J Immunol; 1985 Feb; 134(2):1003-9. PubMed ID: 3871205
[TBL] [Abstract][Full Text] [Related]
16. Purification of human interleukin 2 produced from normal human peripheral blood mononuclear cells.
Kermani-Arab V; Uittenbogaart C; Bramhall J
Thymus; 1986; 8(1-2):3-11. PubMed ID: 3487853
[TBL] [Abstract][Full Text] [Related]
17. The purification and properties of human T cell growth factor.
Mier JW; Gallo RC
J Immunol; 1982 Mar; 128(3):1122-7. PubMed ID: 6976987
[TBL] [Abstract][Full Text] [Related]
18. Mutant EL-4 thymoma cells polyclonally activate murine and human B cells via direct cell interaction.
Zubler RH; Erard F; Lees RK; Van Laer M; Mingari C; Moretta L; MacDonald HR
J Immunol; 1985 Jun; 134(6):3662-8. PubMed ID: 3886789
[TBL] [Abstract][Full Text] [Related]
19. A biochemical variant of human T cell growth factor produced by a cutaneous T cell lymphoma cell line.
Gootenberg JE; Ruscetti FW; Gallo RC
J Immunol; 1982 Oct; 129(4):1499-505. PubMed ID: 6980938
[TBL] [Abstract][Full Text] [Related]
20. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.
Rubin LA; Kurman CC; Fritz ME; Biddison WE; Boutin B; Yarchoan R; Nelson DL
J Immunol; 1985 Nov; 135(5):3172-7. PubMed ID: 3930598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
